Double-blind placebo-controlled trial of omeprazole in children with cystic fibrosis and gastroesophageal reflux disease
primary studies congress abstract
Details- 2019
- Dziekiewicz M
Safety, Efficacy, and Tolerability of Tezacaftor/Ivacaftor in Cystic Fibrosis Patients Who Previously Discontinued Lumacaftor/Ivacaftor Due To Respiratory Adverse Events: a Randomized, Double-Blind, Placebo-Controlled Phase 3b Study
primary studies congress abstract
Details- 2019
- Schwarz C
Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial (EVOLVE)
primary studies congress abstract
Details- 2019
- Sommerburg O
Alternative therapies in patients with cystic fibrosis who carry minimal residual function mutations
primary studies congress abstract
Details- 2019
- Tosco A
Is telehealth as effective as face to face therapy for delivery of whole body vibration training (WBVT) as an adjunct to physiotherapy in children and young people with cystic fibrosis (CF)?
primary studies congress abstract
Details- 2019
- Alexander E
Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: a randomized multicenter study
primary studies congress abstract
Details- 2019
- Dolce D
Stability of serum precipitins to Aspergillus fumigatus for the diagnosis of allergic bronchopulmonary aspergillosis
primary studies congress abstract
Details- 2019
- Lau KSK
Inhaled dry powder alginate oligosaccharide (OligoG) in cystic fibrosis: sub-group analyses of a double-blind, randomized, placebo-controlled, efficacy and safety trial
primary studies congress abstract
Details- 2019
- Rye P
A prospective mixed-methods pilot study assessing the effects of improving diabetes education in adults with cystic fibrosis (IDEA-CF)
primary studies congress abstract
Details- 2019
- Sunsoa HK
Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing classic treatment protocols with classic treatment together with antibiotic treatment of upper airways
primary studies congress abstract
Details- 2019
- Taccetti G